What Cabaletta Bio, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 8 |
| Sells | 0 | 0 |
| Total trades | 0 | 8 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 132,073 |
| Disposed | 0 | 0 |
| Net activity | +0 | +132,073 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Binder Gwendolyn | President, Science & Tech. | Jan 21 | Open-market buy · P | +11,312 | $2.19 | +$24.8K | 31,312 |
| Chang David J. | Chief Medical Officer | Jan 21 | Open-market buy · P | +8,800 | $2.26 | +$19.9K | 8,800 |
| Nichtberger Steven | President & CEO | Jan 21 | Open-market buy · P | +45,000 | $2.24 | +$101K | 1,031,483 |
| Gerard Michael | General Counsel | Jan 21 | Open-market buy · P | +6,600 | $2.27 | +$15K | 6,600 |
| Gavel Steve | Chief Commercial Officer | Jan 21 | Open-market buy · P | +22,170 | $2.27 | +$50.2K | 22,170 |
| Simon Mark | Director | Jan 21 | Open-market buy · P | +11,061 | $2.28 | +$25.3K | 147,205 |
| Bollard Catherine | Director | Jan 21 | Open-market buy · P | +4,405 | $2.27 | +$9.98K | 5,405 |
| Tomasello Shawn | Director | Jan 21 | Open-market buy · P | +22,725 | $2.21 | +$50.3K | 22,725 |
| Binder Gwendolyn | See Remarks | Jan 19 | Open-market sale · S | −700 | $20.33 | −$14.2K | 20,000 |
| Binder Gwendolyn | See Remarks | Jan 19 | Open-market sale · S | −10,300 | $19.54 | −$201K | 20,700 |
| Binder Gwendolyn | See Remarks | Jan 19 | Exercise / conversion · M | +11,000 | $1.01 | +$11.1K | 31,000 |
| Binder Gwendolyn | See Remarks | Dec 19 | Open-market sale · S | −3,132 | $22.22 | −$69.6K | 20,000 |
| Binder Gwendolyn | See Remarks | Dec 19 | Open-market sale · S | −7,868 | $21.76 | −$171K | 23,132 |
| Binder Gwendolyn | See Remarks | Dec 19 | Exercise / conversion · M | +11,000 | $1.01 | +$11.1K | 31,000 |
| Binder Gwendolyn | See Remarks | Nov 20 | Open-market sale · S | −7,458 | $18.02 | −$134K | 20,000 |
| Binder Gwendolyn | See Remarks | Nov 20 | Open-market sale · S | −3,542 | $17.39 | −$61.6K | 27,458 |
| Binder Gwendolyn | See Remarks | Nov 20 | Exercise / conversion · M | +11,000 | $1.01 | +$11.1K | 31,000 |
| Binder Gwendolyn | See Remarks | Oct 19 | Open-market sale · S | −408 | $14.28 | −$5.82K | 20,000 |
| Binder Gwendolyn | See Remarks | Oct 19 | Open-market sale · S | −10,592 | $13.32 | −$141K | 20,408 |
| Binder Gwendolyn | See Remarks | Oct 19 | Exercise / conversion · M | +11,000 | $1.01 | +$11.1K | 31,000 |
Loading...